Digests

June 2026

The Month in Ovarian Cancer Research

June brought major advances in ovarian cancer research, led by a study suggesting some people with exceptional long-term responses to PARP inhibitors may achieve a functional cure. Other research examined PARP use in older adults, predictors of maintenance benefit, aerosolized intraperitoneal chemotherapy, racial disparities, hope in advanced disease, and low-grade serous cancer.

June 2026

The Month in Cervical Cancer Research

June 2026 marked a milestone in cervical cancer prevention: the first national-level evidence showed HPV vaccination is preventing cervical cancer deaths, not just infections or precancers. Research also advanced screening in remote communities, real-world immunotherapy, HPV vaccination in sub-Saharan Africa, precancer management, and barriers to screening access.

June 2026

The Month in Uterine Cancer Research

June brought important advances in uterine and endometrial cancer research, including stronger evidence supporting immunotherapy combinations for advanced disease, updated guidance on staging and surgery under the FIGO 2023 system, and new insights into survivorship, showing how discrimination and chronic stress can influence outcomes beyond traditional medical factors.

June 2026

The Month in Vaginal & Vulvar Cancer Research

June’s open-access research on vulvar and vaginal cancers highlighted advances in chemoradiation, patient-centered surgical trial design, and reconstructive surgery after Vulvar Paget’s disease. Related studies on HPV persistence, cervical precancer treatment, and vaginal health in cancer survivors also offered insights relevant to preventing and managing HPV-associated vaginal cancer.